SGLT2 inhibitorReviewed for 2026 plan year

Does Blue Cross Blue Shield Cover Jardiance?

The verdict

Covered on most plans

Blue Cross Blue Shield covers Jardiance for type 2 diabetes, heart failure, and CKD across its commercial, ACA, Medicare, and Medicaid plans. Because BCBS is a federation of more than 30 independent regional affiliates — each with its own formulary and PBM — your exact tier, step-therapy rule, and cost-share depend on your specific Blue plan. On commercial plans, metformin-first step therapy is common (MMIT: 38.9% of commercial plans nationally, as of Aug 8, 2025). On Medicare Blue plans, near-zero UM applies and the 2026 IRA MFP of $197 governs.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Blue Cross Blue Shield drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Medicare vs. commercial coverage

Whether Blue Cross Blue Shield covers Jardiance depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Covered on Blue Medicare Part D and Medicare Advantage plans, typically as a Tier 3 preferred brand. Prior authorization and step therapy are essentially nil for Jardiance in Medicare nationwide (MMIT: 0% PA, 0.1% step, as of Aug 8, 2025). The 2026 IRA Maximum Fair Price is $197/30-day supply, effective 1/1/2026. The $2,100 Part D out-of-pocket cap applies. As with any IRA 2026 drug, the MFP is a payer-side price ceiling; your actual copay depends on whether your Blue Medicare plan uses a fixed copay or coinsurance — verify on your plan's Evidence of Coverage.

Commercial / Employer

Group & marketplace plans

Covered

Covered across Blue affiliates on commercial/employer and ACA plans. MMIT data shows 99.7% of commercial plans and 99.9% of ACA plans cover Jardiance nationally (as of Aug 8, 2025). However, commercial and ACA step therapy is common (MMIT: 38.9% commercial, 27.7% ACA) — many Blue commercial plans require a documented metformin trial before approving Jardiance. The applicable PBM varies by affiliate (CVS Caremark, OptumRx, and others). Medicaid Blue-affiliated plans cover Jardiance at $0–$10 typical cost-share, though PA and step therapy are also common in that line of business (MMIT: 25.5% PA, 22.9% step). Identify your specific Blue affiliate from your member ID card and verify your plan's drug list.

The 2 boxes you must tick to get approved

Commercial plans that will consider Jardiance require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 2

0 of 2 requirements selected. Meet all 2 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

Your cost, three ways

What Jardiance actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

~$600+ retail (pharmacy-variable estimate, brand Jardiance, no generic available)

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Tier 3 cost-share varies by Blue affiliate and plan; ~84% of Medicare Part D patients nationally pay $0–$50/month (Boehringer Ingelheim, manufacturer-reported average, not a guarantee)

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Boehringer Ingelheim savings card ~$10/month for commercially insured (not Medicare/Medicaid); availability varies by affiliate and pharmacy — verify with your plan

Reduced copay through the assistance program, where eligible.

All cost figures are estimates; confirm with your specific Blue plan's formulary or Member Services. Medicare cost is governed by the $197 MFP and $2,100 OOP cap in 2026. BCBS affiliates use different PBMs, so one Blue plan's copay does not predict another's.

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Identify your specific Blue affiliate

    Check your insurance ID card for your plan name — it may say Anthem (Elevance), HCSC (BCBS of Illinois, Texas, Oklahoma, New Mexico, or Montana), Florida Blue, Highmark, CareFirst, or another regional Blue. Each affiliate has its own formulary and drug lookup tool.

  2. 2

    Search for Jardiance on your affiliate's drug list

    Log in to your Blue plan's member portal and navigate to the drug formulary or pharmacy benefit section. Search for Jardiance (empagliflozin). Note the tier, any step-therapy or prior-authorization requirement, and your cost-share. If a commercial plan, check whether a metformin-first step applies.

  3. 3

    Call Member Services if the formulary lookup is unclear

    Call the pharmacy benefits number on your insurance card and ask: Is Jardiance covered on my plan? What tier? Is there a step-therapy or PA requirement? What is my estimated copay? Keep notes including the representative's name and reference number.

Options if Blue Cross Blue Shield won't cover Jardiance

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Metformin (generic)

First-line T2D therapy, near-universally Tier 1 at ~$4/month. Most Blue commercial plans require a documented metformin trial before approving Jardiance — it is the prerequisite step.

Farxiga (dapagliflozin) or generic dapagliflozin

Another SGLT2 in the same class; generic dapagliflozin is now available and may be placed on a lower tier by some Blue affiliates. It carries higher commercial step therapy (MMIT: 45.8%) — verify your plan. MFP $178.50 in 2026.

Januvia (sitagliptin) or generic sitagliptin

A DPP-4 inhibitor alternative for T2D. Generic sitagliptin launched May 2026, significantly reducing cash cost. Different drug class than SGLT2; your physician can advise whether it fits your clinical needs.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.